Table 1.
ID | Age | Sex | Disease | FAB | WBC (/μl) | Cytogenetics | Blasts in BM (%) |
---|---|---|---|---|---|---|---|
AML-1 | 59 | M | AML | M2 | 22000 | Normal | 88.0 |
AML-2 | 39 | M | AML | M3 | 5300 | t(15;17) (q22;q12) | 77.0 |
AML-3 | 64 | F | AML | M4 | 144100 | Normal | 82.2 |
AML-4 | 58 | F | AML | M5a | 78500 | Normal | 80.8 |
AML-5 | 72 | M | AML | M0 | 17500 | Complex karyotype | 91.6 |
AML-6 | 39 | F | AML | M4 | 77800 | Complex karyotype | 83.8 |
AML-7 | 50 | F | AML | M1 | 30700 | Normal | 77.2 |
AML-8 | 41 | M | AML | M5a | 129700 | Normal | 88.2 |
AML-9 | 69 | M | AML | M5a | 19000 | 46,XY,t(9;11)(p22;q23) | 92.2 |
AML-10 | 58 | F | AML | M2 | 8100 | 45,X,-X,t(8;21)(q22;q22), del(9)(q) | 74.2 |
Control-1 | 69 | M | DLBCL | – | – | – | – |
Control-2 | 16 | F | AITL | – | – | – | – |
Control-3 | 54 | F | ITP | – | – | – | – |
Control-4 | 51 | M | DLBCL | – | – | – | – |
Control-5 | 27 | M | Kikuchi’s disease | – | – | – | – |